For example, a study of colon cancer with KRAS gene mutation has shown that miR-10b is selectively increased in KRAS wild-type-derived exosomes, whereas miR-100 is increased in KRAS mutant-derived exosomes. This evidence concerns the gene KRAS and malignant colon neoplasm.